Baker Bros. Advisors LP 13D and 13G filings for BeOne Medicines AG:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-06-15 4:40 pm Sale | 2026-06-11 | 13D | BEONE MEDICINES LTD. AMERICAN ONC | Baker Bros. Advisors LP | 115,912,814 8.000% | -5,499 (-0.00%) | Filing |
| 2026-04-16 4:32 pm Sale | 2026-04-16 | 13D | BEONE MEDICINES LTD. AMERICAN ONC | Baker Bros. Advisors LP | 115,918,313 8.000% | -9,358,297 (-7.47%) | Filing |
| 2024-12-10 9:30 pm Sale | 2024-12-09 | 13D | BEONE MEDICINES LTD. AMERICAN ONC | Baker Bros. Advisors LP | 125,276,610 13.000% | -13,401,427 (-9.66%) | Filing |
| 2023-11-14 5:18 pm Sale | 2023-11-14 | 13D | BEONE MEDICINES LTD. AMERICAN ONC | Baker Bros. Advisors LP | 138,678,037 13.000% | -14,300,000 (-9.35%) | Filing |
| 2023-05-05 4:33 pm Sale | 2023-05-03 | 13D | BEONE MEDICINES LTD. AMERICAN ONC | Baker Bros. Advisors LP | 152,978,037 13.000% | -1,337,453 (-0.87%) | Filing |